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Background: Although breast cancer mortality rates are declining in many developed countries, 
recent trends in Brazil reveal increasing mortality rates. As mammography is an important tool in the 
early diagnosis and improved prognosis for breast cancer, we aimed to explore recent trends of 
mammography in the Brazilian public healthcare system (SUS). 
Methods: We extracted a range of data from the DATASUS and SISMAMA online databases for the 
period 2010-2013, for Brazil and all of its regions, to explore patterns and trends in mammography 
within SUS across Brazil.  
Results: On average, over 2010-2013, 18% and 14% of SUS-dependent Brazilian women aged 50-59 
and 60-69 years respectively, were given a screening mammogram. Screening and diagnostic 
mammograms were recorded for females outside of this age range. The South and South-East had 
greater rates of screening and diagnostic mammograms respectively, than other regions. Most 
screening and diagnostic mammograms were categorised as BI-RADS category 1 (‘negative’) or 2 
(‘benign’). There was an average annual increase in numbers of machines in use, machines available 
to SUS and machine usage within SUS in each region.  
Conclusions: Screening mammography rates were much lower than recommended in target age 
groups for mammography in Brazil and both types of mammograms were recorded for women 
younger than usually recommended. More appropriate use of mammography and better use of 
resources, will likely improve the outcomes of breast cancer in Brazilian women in a country with 
wide socio-economic differences, as well as minimise the potential risks associated with 
mammography in younger women. 
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Introduction 
In Brazil, there were an estimated 67,316 new cases of [1] and 13,591 deaths from [2] female breast 
cancer in 2012, corresponding to standardised incidence and mortality rates of 59.5 and 12.0 per 
100,000 respectively [1, 2]. As Brazil continues to move through the demographic transition and its 
ageing population grows [3], the burden of breast cancer in Brazilian women is predicted to increase 
over time [1].  
Breast cancer incidence rates are reported to be higher in the more developed regions (South-East 
and South), compared to the less developed regions (North and North-East) of Brazil [4]. Although 
many countries in Northern and Western Europe are also experiencing increasing breast cancer 
incidence, mortality rates from the disease are declining [5], highlighting positive developments in its 
detection and treatment. In comparison, the world standardised mortality rate for breast cancer in 
Brazil increased from 8.61 to 12.66 per 100,000 women between 1979 and 2013 [2]. Studies 
exploring trends over time suggest the more developed regions are experiencing a stabilisation or 
decline in breast cancer mortality, whilst less developed regions are experiencing an increase [6-8].  
Brazil’s healthcare system has both public and private systems. Approximately 75% of the population 
depend solely upon the public subsector- the ‘Sistema Único de Saúde’ (SUS), providing free and 
universal health coverage to its population [3, 9]. The National Institute of Cancer in Brazil (INCA), 
recommends screening by mammography in women aged 50-69 years at average risk of breast 
cancer with a maximum of 2 years between mammograms, and annual mammograms in women 
from 35 years if at high risk for breast cancer [10]. However, Brazil does not have a national breast 
screening programme and responsibility lies with local health authorities to organise and implement 
such programmes [11].  
As breast cancer mortality rates continue to increase in Brazil, there is a need for information on 
screening for breast cancer in Brazilian women, particularly in those dependent upon SUS, who are 
most likely vulnerable to inequalities in the diagnosis and treatment of breast cancer. Therefore, this 
paper aims to explore recent trends and patterns in mammography among SUS-dependent women 
in Brazil.  
Methods 
The Informatics Department of SUS (Departmento de Informática do SUS, DATASUS) online database 
holds a wide range of extractable data on healthcare in Brazil [12]. From here, we went on to extract 
the annual number of mammograms funded by SUS from the Outpatient Information System 
(Sistema de Informações Ambulatoriais do SUS, SIA/SUS) [13]. Mammograms were classified by 
clinical indication as either ‘screening’ or ‘diagnostic’ examinations which were those conducted in 
women presenting without or with the signs or symptoms of breast cancer respectively. Specifically, 
examinations were defined as bilateral screening mammograms (Mamografia Bilateral Para 
Rastreamento, the examination of both breasts in one woman) or unilateral diagnostic 
mammograms (Mamografia) [13]. For the latter, the examination of one woman usually results in 
two recorded approved procedures, as one woman usually gets both breasts examined [14]. 
Therefore we halved the number of diagnostic mammograms for our analysis. We also extracted 
mammography machine and population data from DATASUS [12]. Numbers of machines in use (all 
public and private scanners in operation) and available to SUS (available to use by the public 
healthcare system) were obtained for each month of the study period and were subsequently 
averaged by year [15]. Population data were obtained from either census/inter-census estimates 
[16] or population projections for 2013 [17].  
We extracted the annual number of mammograms by mammography result from the SISMAMA 
database [18]. Mammography results were classified using the ‘Breast Imaging Reporting and Data 
System’ (BI-RADS, categories 0-6) developed by The American College of Radiology (ACR) [19]. BI-
RADS categories range from category 1- ‘negative’ to category 5- ‘highly suggestive of malignancy’ 
with category 0 indicating an ‘incomplete’ examination and category 6, a ‘known biopsy-proven 
malignancy’ [19].  
Data from both databases were restricted to females, for the period 2010-2013, for Brazil and for 
each of its geographical regions: North, North-East, South-East, South and Mid-West. This study 
period was chosen as nationwide implementation of SISMAMA occurred in 2009 [20] with likely 
limited data entry for that year. Data for 2014 were still likely to be entering the system and data for 
later years were not complete at the time of analysis.  
We extracted data for private health insurance coverage for women living in Brazil and its regions 
(Table 2) from The National Agency of Complementary Healthcare (Agência Nacional de Saúde 
Suplementar, ANS) website [21] by age and for each year of the study period. Data are updated 
quarterly and at time of analysis, only data from September of each year were available- which we 
used [21].  
The population of women mainly dependent on SUS was estimated as the proportion of the 
population within each age band (10-14, 15-19, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79 and ≥80 
years) [16, 17, 21] that did not have private health insurance coverage. The total SUS- dependent 
population for Brazil and each region was considered as the sum of their respective SUS-dependent 
populations within each age band. 
Crude mammography rates were calculated as the annual number of mammograms per 100,000 SUS 
dependent women, according to clinical indication, for Brazil and each geographical region for each 
year of the study period and were subsequently averaged. Age-standardized mammography rates 
for Brazil’s regions were obtained using the 2010 Brazilian SUS-dependent female population as a 
standard. Rates were calculated by multiplying the crude age-specific mammography rates by the 
respective proportion of each age group in the standard population which were then summed for 
each region. We also calculated the average number and proportion of mammograms per BI-RADS 
category by clinical indication for the period 2010-2013 for Brazil and its geographical regions. 
For Brazil and its regions, for each year of the study period, we calculated the number of machines in 
use per million population of females and machines available to SUS per million SUS-dependent 
females. Rates of mammograms performed per machine available to SUS were calculated using the 
annual number of mammograms (both screening and diagnostic) and the number of SUS-available 
machines. 
The compound annual growth rate (CAGR) over the study period was calculated using the following 
equation: CAGR= [(Nf/Ni)1/(Yf-Yi)]-1 [22]  
where Nf= Number in final year, Ni= Number in initial year, Yf= Final year, Yi= Initial year. 
Results 
Screening mammograms increased and diagnostic mammograms decreased for Brazil from 2010-
2013 (Table 1). Age standardisation revealed screening mammography rates in the South were 3% 
greater than in the South-East, but over 3.5 times greater than in the North (Table 2). Diagnostic 
mammography rates in the South-East were 31% higher than in the South, but over 2.5 times 
greater than the North (Table 2).  
Overall, screening and diagnostic mammography rates were highest in those aged 50-59 years. Both 
types of mammograms were recorded for women outside of this age range (Table 2). On average, 
18% and 14% of SUS-dependent women aged 50-59 and 60-69 years respectively, were given a 
screening mammogram and less than 1% of 50-59 and 60-69 year old women were given a 
diagnostic mammogram in Brazil between 2010 and 2013. Most screening and diagnostic 
mammograms in each region of Brazil were classified as BI-RADS category 1 or 2 (Table 3). 
The rate of machines in use and available to SUS as well as machine usage rates are shown in Table 
4. All geographic regions experienced an average annual increase in all of these rates.  
Discussion 
Screening and diagnostic mammography rates were highest in 50-59 year olds, but many 
mammograms were recorded outside of this age range. Age standardisation highlighted regional 
differences, with the South and South-East having higher rates of mammograms than any other 
region. Most mammograms were classified as ‘negative’ or ‘benign’ [19]. All regions experienced 
average annual increases for machines in use, machines available to SUS and machine usage rates 
over the study period.  
On average, screening rates in target age groups for Brazil (18% of 50-59 and 14% of 60-69 year olds) 
were much lower than the target of 60% coverage proposed by the Brazilian Ministry of Health [23] 
or 70% coverage of women aged 50-69 years, screened every 2 years, set as an indicator parameter 
by the SUS Performance Index (IDSUS) [24]-  even if we had assumed all women had a screening 
mammogram biennially and that screening cycles did not overlap (35% of 50-59 and 29% of 60-69 
year olds). In comparison, the UK’s National Health Service (NHS) Breast Screening Programme has 
set a minimum coverage target of 70% [25] and achieved 75.9% coverage of 53-70 year olds by 
March 2014 [25], whilst the USA achieved 71.4% coverage of 50-64 year olds in 2013 [26]. 
High rates of mammography were also seen in 40-49 year olds, in some regions, exceeding rates in 
60-69 year olds. Several Brazilian medical societies have recommended annual mammography for 
women aged 40-69 years at average risk for breast cancer [27]. With most mammograms within SUS 
being opportunistic, it is likely that medical professionals are following these recommendations, 
rather than those made by INCA of mammography in 50-69 year old women [10]. In addition, better 
response to media campaigns on the importance of early diagnosis by younger women, may be 
contributing to more frequent medical visits and hence mammography within this group [28]. 
Indeed, increasing numbers of medical visits have been previously shown to be positively associated 
with having a mammogram in Brazil [29].  
We found regional variation in coverage rates, with the highest rates of screening mammograms in 
50-69 year olds found in the South compared to lowest rates in the North. Differences in screening 
rates may be attributed to regional differences in the distribution of breast cancer across Brazil, with 
early detection measures being concentrated and driven in those regions with highest breast cancer 
incidence and mortality rates. However, breast screening services need to adapt to the increasing 
breast cancer incidence and mortality rates facing less developed regions [6-8] as they experience 
demographic changes.  
Regional variation can also be linked to development levels. The South-East only makes up 11% of 
Brazil’s geography, yet accounts for 56% of Brazil’s gross domestic product (GDP) [9] in comparison 
to the North and North-East which are the poorest regions of Brazil [9]. Greater investment into 
outpatient services can be made by more developed regions.  
We found that Brazil had 45.5 mammography machines in use per million women and 27.3 machines 
available to SUS per million SUS-dependent women, in 2013. This was greater than the 1 per every 
240,000 inhabitants recommended by Brazilian health authorities in 2002 [30]. Therefore, it would 
seem that Brazil has an adequate number of mammography machines for SUS and for its population 
of women overall. However, the distribution of mammography machines within each geographic 
region is quite heterogeneous and has previously been documented [31]. Similarly in our study, rates 
of mammography machines in use and available to SUS in 2013 were lowest in the North and North-
East although the proportion of women dependent upon SUS was greatest in these regions [16, 17, 
21]. Average annual growth rates however, were greatest in the North-East followed by the North 
for machines in use, and in the North-East for machines available to SUS. This may be a result of 
saturation of mammography units in more developed regions of the country, with more growth in 
areas of need.  
All regions experienced average annual increases in screening mammograms which largely 
contributed to the increase in machine usage rates seen. Mammography rates found in our study 
were lower than those found in previous population based studies of mammography in Brazil [32-
34], as we focussed on mammography in SUS-dependent women only. It is well documented that 
mammography coverage rates in Brazil are much higher in women with private health insurance [29, 
32].   
We found both diagnostic and screening mammograms recorded for women younger than usually 
recommended. Mammography in young women may be even more frequent in the private sector. 
Indeed, it has been reported that the median age of women having their first mammogram was 
lower in private (40.2 years) compared to public (46.8 years) services [35]. Of those who had 
undergone a previous mammogram, the majority of private service users (64.7%) had between 2 
and 6 previous mammograms compared to only 1 previous mammogram for the majority (51.2%) of 
public service users [35]. Although less common, breast cancer in young women does occur with 
approximately 6.6% of all cases diagnosed in <40 years, 2.4% in <35 years and 1% in <30 years [36]. 
In Brazil, approximately 19% of female breast cancers occur in women aged <45 years [1], almost 
twice that in the USA (11%) and the UK (10%) [1]. Potential reasons for this have been discussed 
elsewhere [37]. Therefore, performance of diagnostic mammograms in young women experiencing 
the signs and symptoms of breast cancer is important. However, age is still an important risk factor 
for the development of breast cancer, with incidence increasing with age [38]. In addition, exposure 
to ionising radiation is a risk factor for cancer induction [39, 40]. It has also been suggested that age 
at exposure is a risk factor for breast cancer induction, with those exposed at younger ages at a 
higher risk [40-43]. Screening mammography of young asymptomatic women in the absence of 
breast cancer risk factors, can unnecessarily expose them to these potential harms and is therefore 
not recommended [44]. Furthermore, mammographic performance in young women is known to be 
poor [45]. Importantly, despite the potential risks, radiation doses from mammography are very low 
in comparison to other imaging modalities such as computed tomography (CT) [46] and the benefits 
of mammography in terms of reduction in relative risk of breast cancer mortality, for women aged 
50-70 years, have been identified [47].  
The majority of cases of breast cancer in Brazil occur in older women. Therefore, in a country with 
wide socio-economic differences [3], which lacks a population based screening programme [11] and 
has limited healthcare resources [9], it is essential to achieve efficient use of mammographic 
screening in target age groups in order to minimise the potential problems and risks of 
mammography in young women and reduce the wastage of resources, incurred by screening young 
women.  
A strength of this study was the use of the SIA/SUS and SISMAMA databases [13] [48] which collate 
information on mammograms conducted within Brazil’s public health system [13] [49]. This enabled 
us to explore mammography within SUS and women dependent upon SUS unlike previous studies 
[32-34]. Additionally, initial analysis of the preliminary findings from the SISMAMA database [20] did 
not report detailed age specific mammography rates- as in our study.  
We found that the number of mammograms reported within the SIA/SUS database were higher than 
that in the SISMAMA database, reflecting underreporting within the SISMAMA database. Therefore, 
we extracted mammography data from the SIA/SUS database, but used SISMAMA for data on BI-
RADS categorisation of mammograms as the SIA/SUS database did not record this. Therefore, the 
results reported in our study on the BI-RADS categorisation of mammograms recorded within 
SISMAMA were likely to be underestimates. The data used to obtain our results were from a limited 
time period- 2010-2013, however, the study period chosen was likely to have the most complete 
data for the SISMAMA database.  
Diagnostic mammograms recorded in women outside of those aged 40-69 years could partly be 
explained by inaccuracies in recording data within the SIA/SUS database. We halved the number of 
diagnostic procedures recorded within the SIA/SUS database for our study as the diagnostic 
examination of one woman would result in two records within the system. We must consider that 
there would be some cases in which only one breast was examined, for example, within a woman 
who has had a previous mastectomy, however, this information was not available.  
Although INCA recommends a maximum of 2 years between screening mammograms for women 
aged 50-69 years at average risk of breast cancer [10], we did not halve the population of SUS-
dependent women for calculation of mammography rates in our study. This was because data on 
time between mammograms was not available within the SIA/SUS database, in addition to taking 
into consideration the overlapping of the female population between screening cycles. Had we done 
so, screening rates would be approximately twice that reported in our study and therefore, our rates 
could be considered underestimates. However, when taking into account information from the 
SISMAMA database about time since the last mammogram, there is evidence to suggest that many 
Brazilian women undergo annual mammograms. For those mammograms recorded for women 
within the SISMAMA database, the time since the last mammogram was 1 year for 27%, 28%, 29% 
and 27% of diagnostic mammograms and 23%, 23%, 22% and 21% of screening mammograms in 
2010, 2011, 2012 and 2013 respectively [18]. These proportions were greater than the proportion of 
women who had their last mammogram <1 year, 2 years, 3 years or ≥4 years previously [18]. 
A further limitation was the assumption that all mammograms recorded within the databases used, 
were on women solely dependent upon SUS, as women with private health insurance are also able 
to access mammography through SUS. Although roughly three-quarters of Brazilian women do not 
have private health insurance [3, 21], coverage varies greatly and in some cities, the proportion of 
women with private health insurance is much greater, for example in Rio de Janeiro and São Paulo in 
which 38.9% and 45.4% of women respectively had private health insurance in 2013 [21]. This may 
have resulted in some overestimation of mammography rates in SUS, availability of machines to SUS 
and rates of machine usage within SUS. However, the limitations of universal healthcare systems like 
SUS, such as long waiting times and limited resources [50], mean that those with private health 
insurance would likely use private services over public ones [50]. Therefore, the impact of this on our 
results is likely to be minimal.   
Overall, although Brazil seems to have an adequate number of mammography units, their use seems 
to be largely inappropriate, reflected both in poor levels of coverage of the target age range for 
mammography- women aged 50-69 years, and in the use of mammography in young women. The 
latter is worrying, especially due to the potential harms of poor mammographic performance and 
risk of breast cancer induction at young ages. Regional differences in mammography rates in the 
correct age groups and the number of mammography units highlights inequalities which need to be 
addressed in order to tackle morbidity and mortality from breast cancer, which is likely to grow in 
less developed regions of Brazil undergoing demographic changes. 
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Table 1: Number of mammograms by type for Brazil and its regions, 2010-2013 
Diagnostic mammogramsa 
Region 2010 2011 2012 2013 CAGRb 
Brazil 230,036.0 196,385.5 190,982.5 187,140.0 -6.6% 
North 10,857.0 8,181.0 6,830.0 4,038.5 -28.1% 
North-East 40,167.0 37,888.5 40,324.5 34,851.5 -4.6% 
South-East 134,786.5 105,353.5 97,804.5 94,388.5 -11.2% 
South 32,276.5 32,266.0 34,736.0 36,742.5 4.4% 
Mid-West 11,949.0 12,696.5 11,287.5 17,119.0 12.7% 
Screening mammograms 
Region 2010 2011 2012 2013 CAGRb 
Brazil 3,039,269 3,560,007 3,979,956 4,287,889 12.2% 
North 67,478 81,832 107,503 124,580 22.7% 
North-East 562,579 702,567 895,594 942,284 18.8% 
South-East 1,569,134 1,840,372 1,987,840 2,166,180 11.3% 
South 722,207 807,677 838,976 892,355 7.3% 
Mid-West 117,871 127,559 150,043 162,490 11.3% 
a=Half the number of diagnostic mammograms extracted from the SIA database.  



















Table 2: Crude and standardised rates of mammography by type per 100,000 SUS-dependent 
females for Brazil and its regions, 2010-2013 
Diagnostic mammography rates per 100,000 SUS-dependent females 
Age group 
(Years) 
Brazil North North-East South-East South Mid-West 
10-14 0.5 0.3 0.2 0.5 1.5 0.3 
15-19 4.8 2.8 1.5 5.0 15.7 2.7 
20-29 22.5 13.6 7.7 23.3 72.7 12.4 
30-39 150.0 77.2 88.0 193.8 280.8 93.2 
40-49 642.8 375.3 501.0 846.1 578.1 604.2 
50-59 883.8 488.7 560.9 1,205 836.7 814.4 
60-69 819.9 375.3 438.1 1,196 817.4 704.9 
70-79 590.2 203.5 276.5 919.1 571.9 476.9 
≥80 295.9 83.0 116.3 523.9 254.6 186.4 
Total 271.6 104.4 157.6 415.5 319.7 223.3 
Standardised 













Screening mammography rates per 100,000 SUS-dependent females 
Age group Brazil North North-East South-East South Mid-West 
10-14 0.0 0.0 0.0 0.0 0.0 0.0 
15-19 0.0 0.0 0.0 0.0 0.0 0.0 
20-29 0.0 0.0 0.0 0.0 0.0 0.0 
30-39 1,609 407.2 1,135 2,184 2,854 617.2 
40-49 14,417 5,457 10,395 18,955 19,494 7,141 
50-59 17,740 6,695 12,622 22,446 23,167 9,087 
60-69 14,464 4,978 9,647 18,885 18,937 7,039 
70-79 7,278 2,474 4,270 10,047 9,226 3,681 
≥80 2,271 870.5 1,293 3,441 2,434 1,259 
Total 5,016 1,321 3,186 7,271 7,665 2,350 
Standardised 













Proportion of women with private health insurance coverage (%)b 
 Brazil North North-East South-East South Mid-West 
% coverage 25.0 11.0 12.0 38.0 25.0 18.0 
aCrude mammography rates were standardised to the 2010 female SUS-dependent population of 
Brazil 
bAverage private health insurance coverage over the study period (2010-2013) extracted from the 
ANS website [21].  
Table 3: Average number (%) of diagnostic and screening mammograms classified as BI-RADS categories 0-6 between 2010 and 2013 
Average number (%) of diagnostic mammograms classified as BI-RADS categories 0-6 
BI-RADS 
Category 
Brazil North North-East South-East South Mid-West 
0 9,526 (10.4) 436 (11.0) 2,522 (14.4) 4,699 (9.0) 1,135 (10.6) 734 (10.7) 
1 32,679 (35.8) 2,515 (63.5) 8,977 (51.2) 13,516 (25.9) 4,373 (40.7) 3,298 (47.9) 
2 33,373 (36.6) 710 (17.9) 3,828 (21.8) 22,493 (43.2) 4,052 (37.7) 2,290 (33.3) 
3 9,411 (10.3) 159 (4.0) 1,271 (7.2) 6,970 (13.4) 698 (6.5) 313 (4.5) 
4 3,882 (4.3) 91 (2.3) 614 (3.5) 2,691 (5.2) 351 (3.3) 136 (2.0) 
5 654 (0.7) 14 (0.3) 82 (0.5) 475 (0.9) 48 (0.4) 35 (0.5) 
6 1,703 (1.9) 36 (0.9) 247 (1.4) 1,249 (2.4) 90 (0.8) 81 (1.2) 
Total 91,227 (100.0) 3,960 (100.0) 17,541 (100.0) 52,092 (100.0) 10,748 (100.0) 6,887 (100.0) 
Average number (%) of screening mammograms classified as BI-RADS categories 0-6 
BI-RADS 
Category 
Brazil North North-East South-East South Mid-West 
0 314,215 (11.0) 8,227 (9.7) 73,490 (12.8) 170,455 (10.9) 44,077 (8.9) 17,966 (13.2) 
1 1,202,897 (42.2) 43,107 (50.7) 294,916 (51.3) 580,411 (37.2) 224,851 (45.6) 59,612 (43.7) 
2 1,229,755 (43.2) 31,508 (37.1) 189,473 (32.9) 747,895 (48.0) 207,616 (42.1) 53,264 (39.1) 
3 67,351 (2.4) 1,311 (1.5) 10,107 (1.8) 41,671 (2.7) 10,693 (2.2) 3,570 (2.6) 
4 30,542 (1.1) 710 (0.8) 6,413 (1.1) 16,463 (1.1) 5,354 (1.1) 1,602 (1.2) 
5 4,020 (0.1) 130 (0.2) 784 (0.1) 2,174 (0.1) 677 (0.1) 256 (0.2) 
6 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Total 2,848,780 (100.0) 84,993 (100.0) 575,182 (100.0) 1,559,068 (100.0) 493,268 (100.0) 136,269 (100.0) 
 
Table 4: Trends of mammography machines in use, machines available to SUS and machine usage in 
Brazil and its regions, 2010-2013 
Number of machines in use per 1,000,000 population of females 
Region 2010 2011 2012 2013 CAGRa 
Brazil 41.2 43.5 43.8 45.5 3.3% 
North 21.8 24.6 24.3 25.2 5.0% 
North-East 26.6 28.9 30.5 33.2 7.6% 
South-East 52.1 53.9 53.8 55.3 2.0% 
South 45.0 48.1 48.5 49.5 3.2% 
Mid-West 48.6 50.9 49.5 51.0 1.6% 
Number of machines available to SUS per 1,000,000 SUS-dependent females 
Region 2010 2011 2012 2013 CAGRa 
Brazil 24.2 25.9 25.6 27.3 4.1% 
North 14.2 15.9 14.8 15.0 1.7% 
North-East 16.4 18.0 18.7 21.5 9.4% 
South-East 31.2 32.2 30.8 32.5 1.4% 
South 31.7 35.1 34.9 36.1 4.4% 
Mid-West 23.9 27.0 26.8 27.9 5.4% 
Number of mammograms conducted per machine available to SUSb 
Region 2010 2011 2012 2013 CAGRa 
Brazil 1,831.8 1,958.0 2,205.1 2,195.0 6.2% 
North 776.9 793.1 1,069.4 1,164.8 14.5% 
North-East 1,520.8 1,702.5 2,056.2 1,844.8 6.6% 
South-East 2,102.3 2,315.4 2,604.6 2,683.4 8.5% 
South 2,250.0 2,273.7 2,356.1 2,386.9 2.0% 
Mid-West 915.8 874.8 1,022.2 1,075.5 5.5% 
aCAGR= Compound annual growth rate. 
bIncludes both screening and diagnostic mammograms. 
 
